mRNA Vaccines May Do More Than Protect Us From COVID-19
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
By: Sanjay Gupta & M.D. En español Published October 21, 2021
On a cold Sunday night last November, Anthony Fauci, M.D., sat bundled up on his deck, having a (physically distanced) drink with a friend, when the call came. Albert Bourla, the CEO of
Pfizer, was on the other end of the line. “Tony,” Bourla said, “are you sitting down?”
Members only
Bourla had the results from the phase 3 trials on an mRNA-based vaccine. He told Fauci it was “amazing.”
“Tony, it’s more than 90 percent effective at reducing the risk of developing severe COVID!” Bourla said. For a scientist like Fauci, it was a deeply emotional, cathartic moment.